Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$152.99 USD
-2.13 (-1.37%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $152.99 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Quest Diagnostics (DGX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$155.07 | $173.00 | $136.00 | -0.03% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Quest Diagnostics comes to $155.07. The forecasts range from a low of $136.00 to a high of $173.00. The average price target represents a decline of 0.03% from the last closing price of $155.12.
Analyst Price Targets (15)
Broker Rating
Quest Diagnostics currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 2.33 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, five are Strong Buy, representing 33.33% of all recommendations. A month ago, Strong Buy represented 33.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 10 | 10 | 10 | 10 | 11 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.33 | 2.33 | 2.33 | 2.33 | 2.47 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/4/2024 | Robert W. Baird & Co. | Eric W Coldwell | Hold | Hold |
8/28/2024 | Evercore Partners | Elizabeth Anderson | Hold | Hold |
8/27/2024 | Not Identified | Not Identified | Hold | Hold |
7/28/2024 | Piper Sandler | David M Westenberg | Hold | Hold |
7/26/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
7/23/2024 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
7/23/2024 | SVB Securities | Michael Cherny | Hold | Hold |
7/15/2024 | Truist Securities | David S Macdonald | Hold | Hold |
7/10/2024 | Not Identified | Not Identified | Hold | Strong Buy |
4/24/2024 | UBS | Kevin Caliendo | Hold | Hold |
2/7/2024 | Not Identified | Not Identified | Hold | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.33 |
ABR (Last week) | 2.33 |
# of Recs in ABR | 15 |
Average Target Price | $155.07 |
LT Growth Rate | 6.20% |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 45 of 253 |
Current Quarter EPS Est: | 2.27 |
DGX FAQs
Quest Diagnostics Incorporated (DGX) currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms.
The average price target for Quest Diagnostics Incorporated (DGX) is $155.07. The current on short-term price targets is based on 9 reports.
The forecasts for Quest Diagnostics Incorporated (DGX) range from a low of $136 to a high of $173. The average price target represents a decline of $0.03 from the last closing price of $155.12.
The current DOWNSIDE for Quest Diagnostics Incorporated (DGX) is 0.03%
Based on short-term price targets offered by 15 analysts, the average price target for Quest Diagnostics comes to $155.07. The forecasts range from a low of $136.00 to a high of $173.00. The average price target represents a decline of 0.03% from the last closing price of $155.12.